Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Losartan/HCTZ versus losartan monotherapy in pediatric essential hypertension
2007-000690-34Phase 3Terminated
- Sponsor
- Merck & Co.
- Start
- Apr 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in essential hypertension comparing Losartan + hydrochlorothiazide with Losartan monotherapy (2 arms). Primary endpoint: Change in mean trough SiSBP. Started Apr 2007; status: terminated.
02
Drugs
losartanhydrochlorothiazide
03
Conditions
essential hypertension
Beyond the preview
Go deeper on 2007-000690-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-000690-34.